Abcepta is a leading manufacturer of primary antibodies with more than two decades of experience. We meet the ever changing demands of research and drug discovery through a thoughtful target selection process and strengthened validation-standards. Moreover, we strive to continuously improve the customer experience through comprehensive technical support, a world class website, and an easy ordering process.
Company highlights:
- 25,000+ Antibodies are produced and validated in-house to ensure specificity, affinity, and reproducibility.
- 1,000+ new antibodies are released per year.
- Portfolio is proteome-wide, with an emphasis on neuroscience, cancer, metabolism, and immunology.
Abcepta offers the highest quality custom services including custom antibody development, custom peptide synthesis and custom protein expression. Abcepta high affinity ADAs are used by a number of pharmaceutical companies for pharmacokinetic bridging ELISAs and as reference standards in ADA assays, with the appropriate sensitivity, specificity, and selectivity to guide biotherapeutic drug development decision-making.